President Donald Trump is scheduled to announce on Friday that “most favored nation” (MFN) drug pricing will be made available to Medicaid programs in all 50 U.S. states for certain prescription drugs. An administration official says Trump will be joined in the Oval Office by several governors as he delivers remarks on the policy.
The announcement is described by outlets as another step in the administration’s efforts to lower prescription drug costs. The Hill reports the expansion will allow all states to access MFN pricing for some drugs within Medicaid, framing the move within broader concerns about affordability. Breitbart adds that the change also covers Washington, D.C., and Puerto Rico, extending the reach beyond the states while still focusing on MFN pricing tied to deals with pharmaceutical companies.
Across coverage, outlets agree on the central action—expanding MFN pricing for certain drugs within Medicaid programs—but differ on how broadly they specify the geographic scope, with one including states only and the other explicitly naming additional jurisdictions.
